Aspirin increases nitric oxide formation in chronic stable coronary disease.

Citation data:

Journal of cardiovascular pharmacology and therapeutics, ISSN: 1940-4034, Vol: 18, Issue: 3, Page: 217-21

Publication Year:
2013
Usage 23
Abstract Views 21
Link-outs 2
Captures 16
Readers 13
Exports-Saves 3
Social Media 2
Tweets 2
Citations 17
Citation Indexes 17
PMID:
23524841
DOI:
10.1177/1074248413482753
PMCID:
PMC4014131; 4014131
ClinicalTrials.gov Identifier:
NCT00272337
Author(s):
Hetzel, Scott; DeMets, David; Schneider, Ricky; Borzak, Steven; Schneider, Wendy; Serebruany, Victor; Schröder, Henning; Hennekens, Charles H
Publisher(s):
SAGE Publications
Tags:
Pharmacology, Toxicology and Pharmaceutics; Medicine
Most Recent Tweet View All Tweets
article description
There are no published randomized data on secondary prevention in humans about whether aspirin affects nitric oxide (NO) formation. In patients with chronic stable coronary disease, we tested whether aspirin at clinically relevant doses increases NO formation.